Technology

Plus Therapeutics

$2.40
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.12 (+5.19%) Today
-$0.03 (-1.23%) As of 10:13 AM UTC after-hours

Why Robinhood?

You can buy or sell PSTV and other stocks, options, and ETFs commission-free!

About PSTV

PLUS THERAPEUTICS, Inc. Common Stock, also called Plus Therapeutics, is a clinical-stage pharmaceutical company, which engages in the discovery, development, and delivery of complex and innovative treatments for patients battling cancer and rare diseases. Its products include Rhenium NanoLiposome (RNL) and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Austin, TX. The listed name for PSTV is PLUS THERAPEUTICS, Inc. Common Stock.

CEO
Marc H. Hedrick
Employees
12
Headquarters
Austin, Texas
Founded
1996
Market Cap
11.87M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
231.55K
High Today
$2.54
Low Today
$2.27
Open Price
$2.27
Volume
307.46K
52 Week High
$3.56
52 Week Low
$0.931

Collections

PSTV Earnings

-$5.12
-$3.19
-$1.27
$0.66
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 29, After Hours

You May Also Like

BMRC
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure